Interferon-free hepatitis C treatment works for people on methadone or

Interferon-free hepatitis C treatment works for people on methadone or
As previously reported, the combination cured 96% of both previously untreated and treatment-experienced patients with genotype 1 HCV infection. Daniel Cohen of AbbVie presented findings from a phase 2 study evaluating the safety and efficacy of the 3D …
Read more here.

Sofosbuvir + GS-5816 for 12 weeks shows high HCV cure rates, but 8 weeks is
The advent of interferon-free therapy using direct-acting antivirals that target different steps of the hepatitis C virus (HCV) lifecycle has brought about a revolution in treatment for chronic hepatitis C. Gilead Sciences' … Stephen Pianko from …
Read more here.

I Have Hepatitis C. What Are My Treatment Options?
As the options for treating hepatitis C (HCV) are increasing, so is the confusion. This is a good problem to have: with more treatment options come more opportunities for people with various HCV genotypes (GT), treatment history and varying levels of …
Read more here.

Sustained virological response represents a long-term cure for people with
Almost all patients with hepatitis C virus (HCV) alone or HIV and HCV co-infection who achieved sustained virological response (SVR) to treatment with sofosbuvir (Sovaldi) plus ribavirin or sofosbuvir/ledipasvir (Harvoni) still had undetectable HCV RNA …
Read more here.

AbbVie next-generation hepatitis C drugs look promising in early studies
The advent of direct-acting antivirals (DAAs) that can be used in interferon-free regimens has brought about a revolution in hepatitis C treatment. The recently approved Harvoni (Gilead Sciences' sofosbuvir/ledipasvir) and Viekirax + Exviera (AbbVie's …
Read more here.

Lessons from Lubitz – why the blame game should carry a health warning
For those people who were infected with HIV or Hepatitis C from blood given to them by the NHS, to wait 30 years for an explanation then only to be told by the Penrose inquiry that effectively nothing could have been done, must have been very difficult …
Read more here.

Active Stocks With Breaking NEWS: KeyCorp. (NYSE:KEY), Gilead Sciences
Private companies in Security Software & Data Analytics will continue to experience triple-digit growth due to high-profile breaches and the willingness from enterprises to invest in security infrastructure. The SaaS space will experience a …
Read more here.

Harvoni Cures Almost All People With Hep C Coinfected With HIV
Twelve weeks of Gilead Sciences' newly approved Harvoni (ledipasvir/sofosbuvir) cured nearly all people with genotype 1 of hepatitis C virus (HCV) who were coinfected with HIV in a recent trial, HIVandHepatitis.com reports. Researchers in the ERADICATE …
Read more here.


Leave a Reply